Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 17:23
05/05/21
05/05
17:23
05/05/21
17:23
GM

General Motors

$57.56 /

+2.215 (+4.00%)

, LYFT

Lyft

$52.61 /

-3.56 (-6.34%)

, TMUS

T-Mobile

$134.14 /

+5.43 (+4.22%)

, FB

Facebook

$315.06 /

-3.54 (-1.11%)

, PTON

Peloton

$82.61 /

-14.26 (-14.72%)

, HNST

Honest Company

$22.95 /

+1.65 (+7.75%)

, PFE

Pfizer

$39.97 /

+ (+0.00%)

, BNTX

BioNTech

$170.68 /

-6.22 (-3.52%)

, GME

GameStop

$159.40 /

-1.6 (-0.99%)

, ATNX

Athenex

$4.57 /

+0.85 (+22.85%)

, HAYW

Hayward

$24.15 /

+4.755 (+24.52%)

, HFC

HollyFrontier

$34.69 /

-1.57 (-4.33%)

, ESPR

Esperion

$20.01 /

-5.585 (-21.82%)

, RDS.A

Royal Dutch Shell

$39.80 /

+1.16 (+3.00%)

, RDS.B

Royal Dutch Shell

$37.47 /

+1.26 (+3.48%)

, MRNA

Moderna

$162.64 /

-11.025 (-6.35%)

, JNJ

Johnson & Johnson

$167.09 /

-0.67 (-0.40%)

The major averages were…

ShowHide Related Items >><<
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

04/22/21 Wolfe Research
Wolfe upgrades Ford with $15 target, sees GM-like 'significant re-rating'
04/20/21 BofA
Lordstown Motors initiated with a Neutral at BofA
04/14/21 Evercore ISI
General Motors price target raised to $65 from $62 at Evercore ISI
04/05/21
Fly Intel: Top five analyst initiations
LYFT Lyft
$52.61 /

-3.56 (-6.34%)

15:41 Today Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
08:50 Today DA Davidson
Lyft price target raised to $72 from $66 at DA Davidson
08:35 Today Susquehanna
Lyft ridesharing recovery taking place, says Susquehanna
07:59 Today Morgan Stanley
Lyft price target raised to $70 from $65 at Morgan Stanley
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
04/19/21 Deutsche Bank
T-Mobile price target raised to $185 from $155 at Deutsche Bank
03/30/21 KeyBanc
KeyBanc sees partnership with Google as neutral to T-Mobile
03/12/21 Morgan Stanley
T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
FB Facebook
$315.06 /

-3.54 (-1.11%)

04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
04/29/21 Truist
Facebook price target raised to $400 from $350 at Truist
04/29/21 Wedbush
Facebook price target raised to $355 from $340 at Wedbush
04/29/21 Canaccord
Facebook price target raised to $380 from $350 at Canaccord
PTON Peloton
$82.61 /

-14.26 (-14.72%)

16:14 Today BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
16:10 Today BofA
Peloton downgraded to Neutral from Buy at BofA
15:55 Today BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
14:21 Today JPMorgan
JPMorgan sees Peloton shares remaining under pressure
HNST Honest Company
$22.95 /

+1.65 (+7.75%)

PFE Pfizer
$39.97 /

+ (+0.00%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
GME GameStop
$159.40 /

-1.6 (-0.99%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Ascendiant
GameStop downgraded to Sell from Hold at Ascendiant
04/06/21 BofA
BofA keeps $10 target on GameStop despite 'positive' funding news
04/05/21 Telsey Advisory
Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump
ATNX Athenex
$4.57 /

+0.85 (+22.85%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
HAYW Hayward
$24.15 /

+4.755 (+24.52%)

04/06/21 Jefferies
Hayward initiated with a Buy at Jefferies
04/06/21 Wolfe Research
Hayward initiated with an Outperform at Wolfe Research
04/06/21 William Blair
Hayward initiated with an Outperform at William Blair
04/06/21 BofA
BofA starts Hayward at Buy with $21 price target
HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

04/01/21 Piper Sandler
HollyFrontier price target raised to $45 from $35 at Piper Sandler
03/17/21 US Capital Advisors
HollyFrontier downgraded to Hold from Overweight at US Capital Advisors
03/08/21 Barclays
HollyFrontier price target raised to $38 from $35 at Barclays
02/26/21 Mizuho
HollyFrontier price target raised to $40 from $25 at Mizuho
ESPR Esperion
$20.01 /

-5.585 (-21.82%)

09:38 Today BTIG
Esperion price target lowered to $71 from $90 at BTIG
08:50 Today Northland
Esperion price target lowered to $24 from $30 at Northland
08:32 Today Credit Suisse
Esperion price target lowered to $36 from $45 at Credit Suisse
06:55 Today Stifel
Stifel downgrades Esperion to Hold with bull case seen 'off the table'
RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
04/01/21 Piper Sandler
Royal Dutch Shell price target raised to $55 from $48 at Piper Sandler
RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
MRNA Moderna
$162.64 /

-11.025 (-6.35%)

17:21 Today Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

07:26 Today Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

  • 05
    May
  • 12
    Mar
  • 10
    Sep
  • 23
    Jul
  • 24
    Jun
  • 19
    May
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HNST Honest Company
$22.95 /

+1.65 (+7.75%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

Upgrade
Evercore upgrades Ultragenyx with 'good handle' on Angelman program » 16:19
05/05/21
05/05
16:19
05/05/21
16:19
RARE

Ultragenyx

$106.22 /

+4.49 (+4.41%)

Evercore ISI analyst…

Evercore ISI analyst Liisa Bayko upgraded Ultragenyx to Outperform from In Line with a $144 price target. The shares have been under pressure as the Angelman program has been "slow to get back up and running," but management now has a good handle on what it will take to reinitiate the study, which should occur around the middle of this year with data updates by year-end, Bayko tells investors in a research note. The analyst says "fully derisked," the Angelman program could be worth $130 per share. And if the program cannot move forward, it represents just $13 of her $144 price target. Bayko finds the "compelling" at current valuation levels.

ShowHide Related Items >><<
RARE Ultragenyx
$106.22 /

+4.49 (+4.41%)

RARE Ultragenyx
$106.22 /

+4.49 (+4.41%)

16:04 Today Evercore ISI
Ultragenyx upgraded to Outperform from In Line at Evercore ISI
04/26/21 Credit Suisse
Ultragenyx assumed with a Neutral at Credit Suisse
03/24/21 Stifel
Stifel remains optimistic on GTX-102 and Ultragenyx ahead of 'important' update
03/01/21 Stifel
Ultragenyx resumed with a Buy at Stifel
RARE Ultragenyx
$106.22 /

+4.49 (+4.41%)

  • 29
    Oct
Upgrade
Ultragenyx upgraded to Outperform from In Line at Evercore ISI » 16:04
05/05/21
05/05
16:04
05/05/21
16:04
RARE

Ultragenyx

$106.14 /

+4.405 (+4.33%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RARE Ultragenyx
$106.14 /

+4.405 (+4.33%)

RARE Ultragenyx
$106.14 /

+4.405 (+4.33%)

04/26/21 Credit Suisse
Ultragenyx assumed with a Neutral at Credit Suisse
03/24/21 Stifel
Stifel remains optimistic on GTX-102 and Ultragenyx ahead of 'important' update
03/01/21 Stifel
Ultragenyx resumed with a Buy at Stifel
02/12/21 Wedbush
Ultragenyx price target raised to $130 from $113 at Wedbush
RARE Ultragenyx
$106.14 /

+4.405 (+4.33%)

  • 29
    Oct
Periodicals
Trade Representative tells Bloomberg U.S. to back vaccine IP protections waiver » 15:27
05/05/21
05/05
15:27
05/05/21
15:27
PFE

Pfizer

$39.34 /

-0.63 (-1.58%)

, MRNA

Moderna

$160.71 /

-12.95 (-7.46%)

, NVAX

Novavax

$176.44 /

-4.93 (-2.72%)

, BNTX

BioNTech

$172.15 /

-4.75 (-2.69%)

The U.S. will support a…

The U.S. will support a proposal to waive intellectual-property protections for COVID-19 vaccines, joining an effort to increase global supply and access to the life-saving shots as the gap between rich and poor nations widens, Bloomberg's Jenny Leonard and Eric Martin report. "We are for the waiver at the WTO, we are for what the proponents of the waiver are trying to accomplish, which is better access, more manufacturing capability, more shots in arms," U.S. Trade Representative Katherine Tai said in an interview with Bloomberg. In afternoon trading, some COVID vaccine makers are trading lower, with Pfizer (PFE) slipping about 1%, Moderna (MRNA) sliding over 5%, Novavax (NVAX) dropping almost 8% and BioNTech (BNTX) sliding over 3%. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

PFE Pfizer
$39.34 /

-0.63 (-1.58%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
MRNA Moderna
$160.71 /

-12.95 (-7.46%)

05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
NVAX Novavax
$176.44 /

-4.93 (-2.72%)

04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

  • 23
    Jul
  • 19
    May
PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

PFE Pfizer
$39.34 /

-0.63 (-1.58%)

NVAX Novavax
$176.44 /

-4.93 (-2.72%)

MRNA Moderna
$160.71 /

-12.95 (-7.46%)

BNTX BioNTech
$172.15 /

-4.75 (-2.69%)

Periodicals
U.S. supports waiver of vaccine-patent protections at WTO, Bloomberg reports » 15:01
05/05/21
05/05
15:01
05/05/21
15:01
PFE

Pfizer

$40.60 /

+0.63 (+1.58%)

, BNTX

BioNTech

$188.50 /

+11.6 (+6.56%)

, MRNA

Moderna

$177.76 /

+4.1 (+2.36%)

, AZN

AstraZeneca

$53.52 /

+0.565 (+1.07%)

, JNJ

Johnson & Johnson

$167.34 /

-0.42 (-0.25%)

, NVAX

Novavax

$190.79 /

+9.42 (+5.19%)

Bloomberg cites comments…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

PFE Pfizer
$40.60 /

+0.63 (+1.58%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$177.76 /

+4.1 (+2.36%)

05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

06:05 Today Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

07:26 Today Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$190.79 /

+9.42 (+5.19%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

  • 23
    Jul
  • 19
    May
PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

PFE Pfizer
$40.60 /

+0.63 (+1.58%)

NVAX Novavax
$190.79 /

+9.42 (+5.19%)

MRNA Moderna
$177.76 /

+4.1 (+2.36%)

JNJ Johnson & Johnson
$167.34 /

-0.42 (-0.25%)

BNTX BioNTech
$188.50 /

+11.6 (+6.56%)

AZN AstraZeneca
$53.52 /

+0.565 (+1.07%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:35
05/05/21
05/05
12:35
05/05/21
12:35
GM

General Motors

$57.72 /

+2.38 (+4.30%)

, LYFT

Lyft

$54.03 /

-2.14 (-3.81%)

, PTON

Peloton

$85.35 /

-11.52 (-11.89%)

, HNST

Honest Company

$23.00 /

+1.7 (+7.98%)

, PFE

Pfizer

$40.84 /

+0.865 (+2.16%)

, BNTX

BioNTech

$193.73 /

+16.83 (+9.51%)

, TMUS

T-Mobile

$134.60 /

+5.89 (+4.58%)

, FB

Facebook

$319.01 /

+0.405 (+0.13%)

, ATNX

Athenex

$5.22 /

+1.5 (+40.32%)

, VERU

Veru

$8.76 /

+0.04 (+0.46%)

, ESPR

Esperion

$19.40 /

-6.19 (-24.19%)

, HFC

HollyFrontier

$33.72 /

-2.54 (-7.00%)

, RDS.A

Royal Dutch Shell

$39.75 /

+1.11 (+2.87%)

, RDS.B

Royal Dutch Shell

$37.42 /

+1.21 (+3.34%)

The major averages are…

ShowHide Related Items >><<
VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

RDS.B Royal Dutch Shell
$37.42 /

+1.21 (+3.34%)

RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

ESPR Esperion
$19.40 /

-6.19 (-24.19%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

ATNX Athenex
$5.22 /

+1.5 (+40.32%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

04/22/21 Wolfe Research
Wolfe upgrades Ford with $15 target, sees GM-like 'significant re-rating'
04/20/21 BofA
Lordstown Motors initiated with a Neutral at BofA
04/14/21 Evercore ISI
General Motors price target raised to $65 from $62 at Evercore ISI
04/05/21
Fly Intel: Top five analyst initiations
LYFT Lyft
$54.03 /

-2.14 (-3.81%)

08:50 Today DA Davidson
Lyft price target raised to $72 from $66 at DA Davidson
08:35 Today Susquehanna
Lyft ridesharing recovery taking place, says Susquehanna
07:59 Today Morgan Stanley
Lyft price target raised to $70 from $65 at Morgan Stanley
07:34 Today Stifel
Lyft price target raised to $60 from $55 at Stifel
PTON Peloton
$85.35 /

-11.52 (-11.89%)

12:16 Today Truist
Peloton recall likely to result in one time financial costs, says Truist
11:01 Today KeyBanc
Peloton Tread, Tread+ recalls a 'clear negative,' says KeyBanc
04/19/21 JPMorgan
Peloton should be bought on pullback from safety warning, says JPMorgan
04/19/21 Truist
CSPC warning unlikely to have material impact on Peloton P&L, saysTruist
HNST Honest Company
$23.00 /

+1.7 (+7.98%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
04/19/21 Deutsche Bank
T-Mobile price target raised to $185 from $155 at Deutsche Bank
03/30/21 KeyBanc
KeyBanc sees partnership with Google as neutral to T-Mobile
03/12/21 Morgan Stanley
T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
FB Facebook
$319.01 /

+0.405 (+0.13%)

04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
04/29/21 Truist
Facebook price target raised to $400 from $350 at Truist
04/29/21 Wedbush
Facebook price target raised to $355 from $340 at Wedbush
04/29/21 Canaccord
Facebook price target raised to $380 from $350 at Canaccord
ATNX Athenex
$5.22 /

+1.5 (+40.32%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
VERU Veru
$8.76 /

+0.04 (+0.46%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
ESPR Esperion
$19.40 /

-6.19 (-24.19%)

09:38 Today BTIG
Esperion price target lowered to $71 from $90 at BTIG
08:50 Today Northland
Esperion price target lowered to $24 from $30 at Northland
08:32 Today Credit Suisse
Esperion price target lowered to $36 from $45 at Credit Suisse
06:55 Today Stifel
Stifel downgrades Esperion to Hold with bull case seen 'off the table'
HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

04/01/21 Piper Sandler
HollyFrontier price target raised to $45 from $35 at Piper Sandler
03/17/21 US Capital Advisors
HollyFrontier downgraded to Hold from Overweight at US Capital Advisors
03/08/21 Barclays
HollyFrontier price target raised to $38 from $35 at Barclays
02/26/21 Mizuho
HollyFrontier price target raised to $40 from $25 at Mizuho
RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
04/01/21 Piper Sandler
Royal Dutch Shell price target raised to $55 from $48 at Piper Sandler
RDS.B Royal Dutch Shell
$37.42 /

+1.21 (+3.34%)

03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

ESPR Esperion
$19.40 /

-6.19 (-24.19%)

ATNX Athenex
$5.22 /

+1.5 (+40.32%)

  • 05
    May
  • 18
    Feb
  • 10
    Sep
  • 23
    Jul
  • 24
    Jun
TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

RDS.B Royal Dutch Shell
$37.42 /

+1.21 (+3.34%)

RDS.A Royal Dutch Shell
$39.75 /

+1.11 (+2.87%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HNST Honest Company
$23.00 /

+1.7 (+7.98%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

ESPR Esperion
$19.40 /

-6.19 (-24.19%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

ATNX Athenex
$5.22 /

+1.5 (+40.32%)

VERU Veru
$8.76 /

+0.04 (+0.46%)

TMUS T-Mobile
$134.60 /

+5.89 (+4.58%)

PTON Peloton
$85.35 /

-11.52 (-11.89%)

PFE Pfizer
$40.84 /

+0.865 (+2.16%)

LYFT Lyft
$54.03 /

-2.14 (-3.81%)

HFC HollyFrontier
$33.72 /

-2.54 (-7.00%)

GM General Motors
$57.72 /

+2.38 (+4.30%)

FB Facebook
$319.01 /

+0.405 (+0.13%)

BNTX BioNTech
$193.73 /

+16.83 (+9.51%)

Hot Stocks
CDC tells Bloomberg will meet on Pfizer COVID-19 shot for teens on May 12 » 10:46
05/05/21
05/05
10:46
05/05/21
10:46
PFE

Pfizer

$40.95 /

+0.9801 (+2.45%)

, BNTX

BioNTech

$190.87 /

+13.97 (+7.90%)

A CDC spokeswoman told…

A CDC spokeswoman told Bloomberg in an email that the CDC has scheduled an advisory committee meeting for May 12 to consider the use of the COVID-19 vaccine developed by Pfizer (PFE) and BioNTech (BNTX) to include individuals 12 to 15 years of age.

ShowHide Related Items >><<
PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

  • 23
    Jul
PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

PFE Pfizer
$40.95 /

+0.9801 (+2.45%)

BNTX BioNTech
$190.87 /

+13.97 (+7.90%)

Hot Stocks
Canada approves Pfizer, BioNTech vaccine for ages 12 to 15 » 10:41
05/05/21
05/05
10:41
05/05/21
10:41
PFE

Pfizer

$40.84 /

+0.87 (+2.18%)

, BNTX

BioNTech

$188.90 /

+12 (+6.78%)

Pfizer Canada (PFE) and…

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has expanded the Interim Order authorization for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in Canada for use in this age group, the companies pointed out. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$40.84 /

+0.87 (+2.18%)

BNTX BioNTech
$188.90 /

+12 (+6.78%)

PFE Pfizer
$40.84 /

+0.87 (+2.18%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
BNTX BioNTech
$188.90 /

+12 (+6.78%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$40.84 /

+0.87 (+2.18%)

  • 23
    Jul
PFE Pfizer
$40.84 /

+0.87 (+2.18%)

BNTX BioNTech
$188.90 /

+12 (+6.78%)

PFE Pfizer
$40.84 /

+0.87 (+2.18%)

BNTX BioNTech
$188.90 /

+12 (+6.78%)

PFE Pfizer
$40.84 /

+0.87 (+2.18%)

BNTX BioNTech
$188.90 /

+12 (+6.78%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 10:36
05/05/21
05/05
10:36
05/05/21
10:36
PFE

Pfizer

$40.74 /

+0.765 (+1.91%)

, NVS

Novartis

$86.15 /

+0.51 (+0.60%)

, LLY

Eli Lilly

$191.49 /

+3.26 (+1.73%)

, GILD

Gilead

$66.32 /

+0.67 (+1.02%)

, SNY

Sanofi

$50.50 /

+0.06 (+0.12%)

, RHHBY

Roche

$40.73 /

-0.62 (-1.50%)

, EXAS

Exact Sciences

$114.64 /

-1.24 (-1.07%)

, NTRA

Natera

$105.90 /

-1.05 (-0.98%)

, SGEN

Seagen

$136.86 /

+0.71 (+0.52%)

ESMO Breast Cancer…

ESMO Breast Cancer Virtual Congress 2021 will be held on May 5-8. Webcast Link

ShowHide Related Items >><<
SNY Sanofi
$50.50 /

+0.06 (+0.12%)

SGEN Seagen
$136.86 /

+0.71 (+0.52%)

RHHBY Roche
$40.73 /

-0.62 (-1.50%)

PFE Pfizer
$40.74 /

+0.765 (+1.91%)

NVS Novartis
$86.15 /

+0.51 (+0.60%)

NTRA Natera
$105.90 /

-1.05 (-0.98%)

LLY Eli Lilly
$191.49 /

+3.26 (+1.73%)

GILD Gilead
$66.32 /

+0.67 (+1.02%)

EXAS Exact Sciences
$114.64 /

-1.24 (-1.07%)

PFE Pfizer
$40.74 /

+0.765 (+1.91%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
NVS Novartis
$86.15 /

+0.51 (+0.60%)

04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
LLY Eli Lilly
$191.49 /

+3.26 (+1.73%)

04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
GILD Gilead
$66.32 /

+0.67 (+1.02%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
SNY Sanofi
$50.50 /

+0.06 (+0.12%)

04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
RHHBY Roche
$40.73 /

-0.62 (-1.50%)

07:18 Today BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
EXAS Exact Sciences
$114.64 /

-1.24 (-1.07%)

08:55 Today Craig-Hallum
Exact Sciences price target lowered to $144 from $161 at Craig-Hallum
08:10 Today BTIG
Exact Sciences price target lowered to $155 from $175 at BTIG
02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
NTRA Natera
$105.90 /

-1.05 (-0.98%)

04/22/21 SVB Leerink
CMS coverage determination a positive for Natera, says SVB Leerink
03/10/21 Piper Sandler
Natera, Genentech start Phase 3 trial using Signatera, says Piper Sandler
02/26/21 Piper Sandler
Natera price target raised to $150 from $127 at Piper Sandler
01/27/21 Truist
Natera initiated with a Buy at Truist
SGEN Seagen
$136.86 /

+0.71 (+0.52%)

04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
SNY Sanofi
$50.50 /

+0.06 (+0.12%)

SGEN Seagen
$136.86 /

+0.71 (+0.52%)

RHHBY Roche
$40.73 /

-0.62 (-1.50%)

PFE Pfizer
$40.74 /

+0.765 (+1.91%)

NVS Novartis
$86.15 /

+0.51 (+0.60%)

NTRA Natera
$105.90 /

-1.05 (-0.98%)

LLY Eli Lilly
$191.49 /

+3.26 (+1.73%)

GILD Gilead
$66.32 /

+0.67 (+1.02%)

EXAS Exact Sciences
$114.64 /

-1.24 (-1.07%)

  • 11
    Sep
SNY Sanofi
$50.50 /

+0.06 (+0.12%)

RHHBY Roche
$40.73 /

-0.62 (-1.50%)

PFE Pfizer
$40.74 /

+0.765 (+1.91%)

NVS Novartis
$86.15 /

+0.51 (+0.60%)

LLY Eli Lilly
$191.49 /

+3.26 (+1.73%)

GILD Gilead
$66.32 /

+0.67 (+1.02%)

SNY Sanofi
$50.50 /

+0.06 (+0.12%)

SGEN Seagen
$136.86 /

+0.71 (+0.52%)

RHHBY Roche
$40.73 /

-0.62 (-1.50%)

PFE Pfizer
$40.74 /

+0.765 (+1.91%)

NVS Novartis
$86.15 /

+0.51 (+0.60%)

NTRA Natera
$105.90 /

-1.05 (-0.98%)

LLY Eli Lilly
$191.49 /

+3.26 (+1.73%)

GILD Gilead
$66.32 /

+0.67 (+1.02%)

EXAS Exact Sciences
$114.64 /

-1.24 (-1.07%)

PFE Pfizer
$40.74 /

+0.765 (+1.91%)

LLY Eli Lilly
$191.49 /

+3.26 (+1.73%)

GILD Gilead
$66.32 /

+0.67 (+1.02%)

Options
Pfizer call volume above normal and directionally bullish » 10:05
05/05/21
05/05
10:05
05/05/21
10:05
PFE

Pfizer

$40.81 /

+0.84 (+2.10%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$40.81 /

+0.84 (+2.10%)

PFE Pfizer
$40.81 /

+0.84 (+2.10%)

07:20 Today JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
06:45 Today Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PFE Pfizer
$40.81 /

+0.84 (+2.10%)

PFE Pfizer
$40.81 /

+0.84 (+2.10%)

PFE Pfizer
$40.81 /

+0.84 (+2.10%)

PFE Pfizer
$40.81 /

+0.84 (+2.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.